Product Information

GS DUAL ACTION PAIN 250-125 MG is a generic product labeled by L. Perrigo Company, priced at $0.0890 per EA under NDC 00113530068. Its NADAC has been published 140 times since Mar 20, 2024.

FDA first approved this application on Feb 28, 2023.

GS DUAL ACTION PAIN 250-125 MG

Acetaminophen, Ibuprofen
$0.0890per EA
OTC

Strength

250; 125 mg/1; mg/1

Manufacturer

L. Perrigo Company

NDC

00113530068

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACETAMINOPHEN; IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA214836

FDA Approved

2/28/2023

On Market Since

3/1/2023

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for GS DUAL ACTION PAIN 250-125 MG has been published 140 times since Mar 20, 2024, and over the history we have for it it has risen 41.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0890 per EA
All-time high$0.1086 (Jul 16, 2025)
All-time low$0.0610 (May 22, 2024)
52-week high$0.1071
52-week low$0.0839
Median price$0.0899
Average price$0.0877
Largest weekly change+15.2% (Jul 17, 2024)
Weeks tracked140
Tracking sinceMar 20, 2024

Price History

1W

-4.6%

1M

-16.9%

3M

-15.9%

6M

+5.5%

1Y

-4.8%

3Y

N/A

5Y

N/A

All

+41.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GS DUAL ACTION PAIN 250-125 MG?

The current National Average Drug Acquisition Cost (NADAC) for GS DUAL ACTION PAIN 250-125 MG, manufactured by L. Perrigo Company, is $0.0890 per EA (NDC 00113530068), effective Nov 18, 2026.

How has the price of GS DUAL ACTION PAIN 250-125 MG changed over time?

Over the history we have for it, the NADAC for GS DUAL ACTION PAIN 250-125 MG has risen 41.2%. It has been tracked across 140 weekly CMS publications since Mar 20, 2024.

What are the highest and lowest recorded NADAC prices for GS DUAL ACTION PAIN 250-125 MG?

Since Mar 20, 2024, the NADAC for GS DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0899 per EA.

Are there cheaper alternatives to GS DUAL ACTION PAIN 250-125 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS DUAL ACTION PAIN 250-125 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures GS DUAL ACTION PAIN 250-125 MG?

GS DUAL ACTION PAIN 250-125 MG (NDC 00113530068) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.